IL200277A0 - Composition for combating epistaxis - Google Patents

Composition for combating epistaxis

Info

Publication number
IL200277A0
IL200277A0 IL200277A IL20027709A IL200277A0 IL 200277 A0 IL200277 A0 IL 200277A0 IL 200277 A IL200277 A IL 200277A IL 20027709 A IL20027709 A IL 20027709A IL 200277 A0 IL200277 A0 IL 200277A0
Authority
IL
Israel
Prior art keywords
epistaxis
combating
composition
combating epistaxis
Prior art date
Application number
IL200277A
Other languages
English (en)
Original Assignee
Pharmaceure Health Care Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaceure Health Care Ab filed Critical Pharmaceure Health Care Ab
Publication of IL200277A0 publication Critical patent/IL200277A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL200277A 2007-02-21 2009-08-06 Composition for combating epistaxis IL200277A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0703377A GB2447012B (en) 2007-02-21 2007-02-21 Composition for combating epistaxis
PCT/GB2008/000608 WO2008102150A2 (en) 2007-02-21 2008-02-21 Composition for combating epistaxis

Publications (1)

Publication Number Publication Date
IL200277A0 true IL200277A0 (en) 2010-04-29

Family

ID=37909023

Family Applications (1)

Application Number Title Priority Date Filing Date
IL200277A IL200277A0 (en) 2007-02-21 2009-08-06 Composition for combating epistaxis

Country Status (19)

Country Link
US (1) US9138406B2 (enExample)
EP (1) EP2117502B1 (enExample)
JP (1) JP2010519285A (enExample)
KR (1) KR20090130001A (enExample)
CN (1) CN101677940B (enExample)
AU (1) AU2008217608B2 (enExample)
BR (1) BRPI0807732B8 (enExample)
CA (1) CA2678706C (enExample)
DK (1) DK2117502T3 (enExample)
ES (1) ES2606947T3 (enExample)
GB (1) GB2447012B (enExample)
HR (1) HRP20161626T1 (enExample)
HU (1) HUE031199T2 (enExample)
IL (1) IL200277A0 (enExample)
PL (1) PL2117502T3 (enExample)
PT (1) PT2117502T (enExample)
RU (1) RU2473327C2 (enExample)
WO (1) WO2008102150A2 (enExample)
ZA (1) ZA200905519B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2447012B (en) 2007-02-21 2011-03-16 Pharmacure Health Care Ab Composition for combating epistaxis
USD993736S1 (en) 2023-05-17 2023-08-01 Line Work Bucket Products, LLC Auger and socket holder
WO2026030821A1 (en) * 2024-08-07 2026-02-12 Conlin Anne Nasal formulations for non-invasive nasal delivery

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4363319A (en) * 1980-06-30 1982-12-14 Applied Medical Devices, Inc. Ready-to-use bandage incorporating a coagulant composition and method of preparing same
JPS63174924A (ja) * 1987-01-14 1988-07-19 Toko Yakuhin Kogyo Kk 軟膏基剤および軟膏剤
AU2793292A (en) * 1991-10-11 1993-05-03 Novo Nordisk A/S Hemostatic composition for local hemostasis
CN1091315A (zh) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
US5928611A (en) * 1995-06-07 1999-07-27 Closure Medical Corporation Impregnated applicator tip
US6365131B1 (en) * 1997-10-31 2002-04-02 J. B. Chemicals & Pharmaceuticals Ltd. Pharmaceutical dental formulation for topical application of metronidazole benzoate, chlorhexidine gluconate and local anesthetic
US6818018B1 (en) * 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
WO2001000218A1 (en) * 1999-06-30 2001-01-04 Scott Cordray Nasal spray having dead sea salts
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
US20030077301A1 (en) * 1999-12-16 2003-04-24 Maibach Howard I. Topical pharmaceutical composition for the treatment of inflammatory dermatoses
RU2156612C1 (ru) * 2000-03-13 2000-09-27 Волков Александр Григорьевич Способ остановки носового кровотечения
US7544348B2 (en) * 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US7303759B2 (en) * 2001-06-22 2007-12-04 The United States Of America As Represented By The Secretary Of The Army Compositions and methods for reducing blood and fluid loss from open wounds
DE10361306A1 (de) * 2003-12-24 2005-07-28 Lts Lohmann Therapie-Systeme Ag Wundauflage und Wundschnellverband mit einem vasokonstriktorischen Inhaltsstoff, sowie Herstellungsverfahren hierfür
CN101001649B (zh) * 2004-07-09 2011-08-31 弗罗桑医疗设备公司 包括透明质酸的止血组合物及其制备方法
GB2409162B (en) * 2004-10-06 2005-12-14 Bhk Holding Ltd Materials,methods,and apparatus for treating a body cavity
RU2290937C1 (ru) * 2005-10-03 2007-01-10 Владислав Владимирович Петров Способ остановки носового кровотечения
GB2447012B (en) 2007-02-21 2011-03-16 Pharmacure Health Care Ab Composition for combating epistaxis

Also Published As

Publication number Publication date
CN101677940B (zh) 2014-02-19
PT2117502T (pt) 2016-12-13
US20100119472A1 (en) 2010-05-13
HUE031199T2 (en) 2017-07-28
JP2010519285A (ja) 2010-06-03
KR20090130001A (ko) 2009-12-17
ZA200905519B (en) 2010-10-27
CN101677940A (zh) 2010-03-24
RU2009134086A (ru) 2011-03-27
EP2117502B1 (en) 2016-11-09
DK2117502T3 (en) 2017-01-23
CA2678706C (en) 2014-11-18
CA2678706A1 (en) 2008-08-28
ES2606947T3 (es) 2017-03-28
GB0703377D0 (en) 2007-03-28
EP2117502A2 (en) 2009-11-18
BRPI0807732A2 (pt) 2014-06-03
AU2008217608A1 (en) 2008-08-28
RU2473327C2 (ru) 2013-01-27
HRP20161626T1 (hr) 2017-03-10
BRPI0807732B1 (pt) 2020-08-04
PL2117502T3 (pl) 2017-08-31
GB2447012B (en) 2011-03-16
WO2008102150A2 (en) 2008-08-28
AU2008217608B2 (en) 2013-01-10
GB2447012A (en) 2008-09-03
BRPI0807732B8 (pt) 2021-05-25
WO2008102150A3 (en) 2009-04-30
US9138406B2 (en) 2015-09-22

Similar Documents

Publication Publication Date Title
GB0718777D0 (en) Composition
GB0700534D0 (en) Composition
GB0717182D0 (en) Composition
GB0722550D0 (en) Composition
GB0714575D0 (en) Composition
GB0710888D0 (en) Composition
SI2154121T1 (sl) Biognojilni sestavek
GB0715068D0 (en) Improved composition
GB0716591D0 (en) Composition
GB0714569D0 (en) Composition
GB0705885D0 (en) Composition
GB0703719D0 (en) Composition
GB0706343D0 (en) Composition
GB0702446D0 (en) Composition
GB2447012B (en) Composition for combating epistaxis
GB0707972D0 (en) Composition
GB0706739D0 (en) Composition
GB0704651D0 (en) Composition
GB0704659D0 (en) Composition
GB0721430D0 (en) Composition
GB0713976D0 (en) Composition
GB0710559D0 (en) Composition
GB0703087D0 (en) Composition
GB0711414D0 (en) Composition
GB0717386D0 (en) Composition